IGC Pharma, Inc.IGCNYSE
Loading
EBITDA Over TimeContracting
Percentile Rank47
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-6.45M
Near historical average
Percentile
P47
Within normal range
Streak
4 yr
Consecutive growthContracting
Average
$-7.02M
Historical baseline
PeriodValueYoY Change
TTM$-6.45M+5.6%
2025$-6.83M+25.5%
2024$-9.16M+15.6%
2023$-10.85M+24.5%
2022$-14.37M-72.4%
2021$-8.33M-24.0%
2020$-6.72M-46.6%
2019$-4.58M-164.1%
2018$-1.74M-42.4%
2017$-1.22M-